+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ifenprodil"

Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019 - Product Thumbnail Image

Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 54 Pages
  • Global
From
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Ifenprodil is a drug used to treat central nervous system (CNS) disorders. It is a selective antagonist of the NMDA receptor, which is involved in the regulation of neuronal excitability. Ifenprodil is used to treat a variety of CNS disorders, including schizophrenia, bipolar disorder, and depression. It is also used to treat anxiety and insomnia. The drug is available in both oral and injectable forms. Ifenprodil is a relatively new drug, and its use is still being studied. It is believed to have fewer side effects than other CNS drugs, and it is thought to be more effective in treating certain conditions. The Ifenprodil market is growing as more people are turning to this drug to treat their CNS disorders. Companies such as Sun Pharmaceuticals, Lupin Pharmaceuticals, and Dr. Reddy's Laboratories are leading the way in the Ifenprodil market. Other companies such as Cipla, Intas Pharmaceuticals, and Glenmark Pharmaceuticals are also involved in the market. Show Less Read more